| |
| |
|
| Insider
Information: |
Milligan John F |
| Relationship: |
Director |
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,574,306 |
|
|
Indirect Shares
|
211,755 |
|
|
| Direct
Value |
$100,566,667 |
|
|
|
Indirect Value
|
$7,138,909 |
|
|
| Total
Shares |
1,786,061 |
|
|
| Total
Value |
$107,705,577 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
President and CEO, Dir... |
2018-11-27 |
1,574,306 |
2012-01-06 |
111,755 |
Premium* |
|
|
4d Molecular Therapeutics Inc. |
FDMT |
Director |
2020-12-15 |
0 |
2020-12-15 |
100,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
159 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2009-03-02 |
4 |
S |
$44.42 |
$2,665,014 |
D/D |
(60,000) |
242,281 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2009-05-07 |
4 |
S |
$44.45 |
$3,880,546 |
D/D |
(87,300) |
249,875 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2009-05-05 |
4 |
S |
$44.49 |
$8,857,723 |
D/D |
(199,092) |
249,875 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2013-03-06 |
4 |
D |
$45.40 |
$1,160,787 |
D/D |
(25,568) |
564,774 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2009-09-01 |
4 |
S |
$45.46 |
$2,727,672 |
D/D |
(60,000) |
250,354 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
COO |
• – – |
2007-12-03 |
4 |
S |
$45.55 |
$2,766,845 |
D/D |
(60,000) |
207,393 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2009-12-01 |
4 |
S |
$46.03 |
$2,761,542 |
D/D |
(60,000) |
250,354 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2012-03-12 |
4 |
D |
$46.16 |
$759,609 |
D/D |
(16,456) |
239,480 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
COO and CFO |
• – – |
2008-03-03 |
4 |
S |
$47.40 |
$2,880,670 |
D/D |
(60,000) |
213,893 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
COO and CFO |
• – – |
2008-03-17 |
4 |
D |
$47.55 |
$304,510 |
D/D |
(6,404) |
221,489 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2008-09-02 |
4 |
S |
$51.69 |
$3,101,400 |
D/D |
(60,000) |
221,489 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• – – |
2005-11-18 |
4 |
S |
$54.34 |
$1,610,338 |
D/D |
(29,600) |
93,021 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• – – |
2005-11-18 |
4 |
S |
$54.53 |
$21,812 |
D/D |
(400) |
119,021 |
|
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2008-06-02 |
4 |
S |
$54.73 |
$3,284,433 |
D/D |
(60,000) |
221,489 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• – – |
2004-02-03 |
4 |
S |
$56.89 |
$398,277 |
D/D |
(7,000) |
44,081 |
|
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2012-09-04 |
4 |
AS |
$57.41 |
$8,037,694 |
D/D |
(140,000) |
259,007 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2017-02-15 |
4 |
A |
$59.33 |
$18,689 |
D/D |
315 |
1,059,278 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• – – |
2004-05-03 |
4 |
S |
$60.11 |
$481,812 |
D/D |
(8,000) |
44,081 |
|
- |
|
| GILD |
Gilead Sciences Inc |
officerTitle |
• – – |
2006-02-06 |
4 |
S |
$60.50 |
$1,815,881 |
D/D |
(30,000) |
98,521 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• – – |
2006-07-25 |
4 |
S |
$60.79 |
$3,648,656 |
D/D |
(60,000) |
98,521 |
|
- |
|
| GILD |
Gilead Sciences Inc |
President and CEO |
• • – |
2018-02-15 |
4 |
A |
$62.35 |
$21,198 |
D/D |
340 |
1,166,264 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• – – |
2003-08-07 |
4 |
S |
$63.21 |
$695,930 |
D/D |
(11,000) |
44,012 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Chief Financial Officer |
• – – |
2004-08-04 |
4 |
S |
$63.50 |
$508,000 |
D/D |
(8,000) |
44,081 |
|
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2013-11-07 |
4 |
AS |
$66.97 |
$26,710,875 |
D/D |
(395,635) |
564,774 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
President and COO |
• – – |
2012-11-02 |
4 |
AS |
$67.01 |
$4,690,672 |
D/D |
(70,000) |
270,187 |
0 |
- |
|
159 Records found
|
|
Page 5 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
